Cardiovascular Drugs and Therapy

, Volume 23, Issue 4, pp 327–331 | Cite as

One Hour Reperfusion is Enough to Assess Function and Infarct Size With TTC Staining in Langendorff Rat Model

  • R. FerreraEmail author
  • S. Benhabbouche
  • J. C. Bopassa
  • B. Li
  • M. Ovize



There is not general agreement concerning the optimal time of reperfusion necessary to assess myocardial function and necrosis on isolated perfused heart model. Nevertheless, the study of cardioprotection (especially, pre– and postconditioning) requires a reliable and standardized assessment of myocardial necrosis.


The objective of this study was thus to evaluate whether 1 h of reperfusion was sufficient to assess rat heart viability on Langendorff preparation. Isolated rat hearts (n = 30) underwent 40 min of global normothermic ischemia followed by 60 or 120 min Langendorff reperfusion. In each group, hearts were also randomly assigned into the 2 following sub-groups: postconditioning (PostC, consisting in 2 episodes of 30 s ischemia and 30 s reperfusion at the onset of reperfusion), and control (no intervention). Coronary flow, heart rate, dP/dt and rate-pressure-product were measured. Myocardial necrosis was assessed by TTC staining and LDH, CK release analysis.


Our results indicated that heart function tended to slightly decrease between 60 min and 120 min reperfusion. Infarct size was identical at 60 min and 120 min reperfusion, averaging 33–34% of total LV area in controls versus 17% in PostC (p < 0.001 between control and PostC groups). Similarly, the maximum of enzymatic releases (CK and LDH) measured in coronary effluents was at 60 min of reperfusion, followed by a progressive decrease at 90 min and 120 min. As expected, postconditioning limited enzymatic releases whatever the studied time of reperfusion.


In conclusion, we showed that prolonged reperfusion beyond 60 min was not useful for function assessment and did not change infarct size measurement, on Langendorff rat model of ischemia-reperfusion.

Key words

Langendorff preparation Infarct size Triphenyltetrazolium Reperfusion 


  1. 1.
    Munujos P, Coll-Canti J, González-Sastre F, Gella FJ. Assay of succinate dehydrogenase activity by a colorimetric-continuous method using iodonitrotetrazolium chloride as electron acceptor. Anal Biochem. 1993;212:506–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Seidler E. The tetrazolium-formazan system: design and histochemistry. Prog Histochem Cytochem. 1991;24:1–86.PubMedGoogle Scholar
  3. 3.
    Ferrera R, Larese A, Berthod F, Guidollet J, Rodriguez C, Dureau G, et al. Quantitative reduction of MTT by heart biopsies in vitro is an index of viability. J Mol Cell Cardiol. 1993;25:1091–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Ferrera R, Bopassa JC, Angoulvant D, Ovize M. Post-conditioning protects from cardioplegia and cold ischemia via inhibition of mitochondrial permeability transition pore. J Heart Lung Transplant. 2007;26:604–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Ito WD, Schaarschmidt S, Klask R, Hansen S, Schafer HJ, Mathey D, et al. Infarct size measurement by triphenyltetrazolium chloride staining versus in vivo injection of propidium iodide. J Mol Cell Cardiol. 1997;29:2169–75.PubMedCrossRefGoogle Scholar
  6. 6.
    Birnbaum Y, Hale SL, Kloner RA. Differences in reperfusion length following 30 min of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining. J Mol Cell Cardiol. 1997;29:657–66.PubMedCrossRefGoogle Scholar
  7. 7.
    Schwarz ER, Somoano Y, Hale SL, Kloner RA. What is the Required Reperfusion Period for Assessment of Myocardial Infarct Size Using Triphenyltetrazolium Chloride Staining in the Rat? J Thromb Thrombolysis. 2000;10:181–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Redel A, Jazbutyte V, Smul TM, Lange M, Eckle T, Eltzschig H, et al. Impact of Ischemia and Reperfusion Times on Myocardial Infarct Size in Mice In Vivo. Exp Biol Med. 2008;233:84–93.CrossRefGoogle Scholar
  9. 9.
    Freeman I, Grunwald MA, Robin B, Rao FS, Bodenheimer MM. Effect of early reperfusion on use of triphenyltetrazolium chloride to differentiate viable from non-viable myocardium in area of risk. Cardiovasc Res. 1990;24:109–14.PubMedCrossRefGoogle Scholar
  10. 10.
    Pitts KR, Stiko A, Buetow B, Lott F, Guo P, Virca D, et al. Washout of heme-containing proteins dramatically improves tetrazolium-based infarct staining. J Pharmacol Toxicol Methods. 2007;55:201–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Benedek A, Moricz K, Juranyi Z, Gigler G, Levay G, Harsing LG, et al. Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res. 2006;1116:159–65.PubMedCrossRefGoogle Scholar
  12. 12.
    Bopassa JC, Michel P, Gateau-Roesch O, Ovize M, Ferrera R. Low-pressure reperfusion alters mitochondrial permeability transition. Am J Physiol Circ Physiol. 2005;288:H2750–5.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • R. Ferrera
    • 1
    • 2
    Email author
  • S. Benhabbouche
    • 1
  • J. C. Bopassa
    • 1
  • B. Li
    • 1
  • M. Ovize
    • 1
  1. 1.INSERM U886Université de LyonLyonFrance
  2. 2.INSERM U886, Laboratoire de PhysiologieFaculté de médecine Lyon-NordLyonFrance

Personalised recommendations